|
|
 |
 - Proven and tested: tool of choice in more than 500 publications
- Exclusive: developed by Miltenyi Biotec, available from Miltenyi Biotec only
- Unique: CD133 antibodies for the analysis of primitive stem cells
|
| Overview |
The CD133/2 (293C3) antibodies allow for the identification and enumeration of CD133+ cells by flow cytometry. - Hematopoietic stem cells from peripheral blood, cord blood, bone marrow, or leukapheresis product.
- Neural progenitor cells from single-cell suspensions from primary neural tissues or cell lines.
- ES and iPS cell derived neural, endothelial, or hematopoietic progenitors from differentiated ES or iPS cell cultures.
- Cancer stem cells from single-cell suspensions from primary tumor tissue or cell lines.
|
| Details |
Background information CD133/2 (293C3) antibodies recognize epitope 2 of the human CD133 antigen (CD133/2). CD133 is a marker that is frequently found on multipotent progenitor cells, including immature hematopoietic stem and progenitor cells. in human fetal liver, bone marrow, cord blood, and peripheral blood. CD133 has also been found to be expressed on circulating endothelial progenitor cells, tissue-specific stem cells, cancer stem cells from tumor tissues, as well as ES and iPS cell-derived cells. |
| Clone | Isotype |
| 293C3 | Mouse IgG2b |
| | |
|
 |
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| CD133/2 (293C3)-PE, human |
- for 100 tests (1) Download datasheet 130-090-853
|
| CD133/2 (293C3)-APC, human |
- for 100 tests (1) Download datasheet 130-090-854
|
| CD133/2 (293C3)-Biotin, human |
- for 100 tests (2) Download datasheet 130-090-852
|
| CD133/2 (293C3) pure, human |
- 50 μg in 1 mL Download datasheet 130-090-851
|
| (1) One test corresponds to fluorescent labeling of up to 107 cells in a total volume of 100 μL. |
| (2) One test corresponds to labeling of up to 107 cells in a total volume of 100 μL. |
|
| MACS Stem Cell newsletter |
|
Stay current with important developments in stem cell research by subscribing to
Stem Cell Updates.
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|